骆佩怡,李晓云
LUO Peiyi,LI Xiaoyun

• 1:广州医科大学附属第二医院

摘要(Abstract)：

目的探讨舒血宁联合贝那普利治疗2型糖尿病合并高血压肾功能损害的临床疗效。方法对2012~2013年院内确诊的2型糖尿病合并高血压并有微量白蛋白尿的180例患者随机分为2组,2组均给予常规降糖治疗,对照组给予贝那普利治疗,治疗组采用舒血宁注射液联合贝那普利治疗,观察2组患者治疗前后血压和肾功能的变化。结果观察组有效率为88.89%,对照组为67.78%,差异具有统计学意义(χ2=11.82,P<0.05);治疗后观察组SBP、DBP、脉压、肌酐、尿微量白蛋白(m Alb)、24 h尿蛋白等指标显著下降,与治疗前比差异具有统计学意义(P<0.05);观察组肌酐、尿微量白蛋白(m Alb)、24 h尿蛋白与对照组治疗后相比较,差异具有统计学意义(P<0.05)。结论舒血宁联合贝那普利能有效改善2型糖尿病合并高血压患者的早期肾损害,延缓病情进展。
OBJECTIVE To study the clinical effect of Shuxuening injections combined with beinazepril on patients with type 2diabetes and hypertensive renal damage. METHODS A total of 180 patients were randomly divided into the treatment[U3]group and the control group,all patients were diagnose with type 2 diabetes between 2012 to 2013. Conventional treatment was given to all patients in the 2 groups. Patients in the control group were treated with beinazepril,and patients in the treatment group were treated with beinazepril combined with Shuxuening injections. After the treatment,the blood pressure and renal function changes in all patients were observed. RESULTS The effective of patients in the treatment group was 88. 89%,and that of the control group was 67. 78%; the difference was statistically significant( χ2= 11. 82,P < 0. 05). After treatment,the indicators of SBP,DBP,PP,creatinine,m Alb,24 h urinary protein of patients in the treatment group were lower than before( P < 0. 05). In patients of the control group,the creatinine,m Alb,24 h urinary protein were lower than before( P < 0. 05). CONCLUSION Combination of Shuxuening injections and beinazepril is more effective in improving early renal damage in patients with type 2 diabetes than beinazepril alone.

关键词(KeyWords)： 舒血宁;贝那普利;糖尿病合并高血压;肾功能
Shuxuening injections;Beinazepril;diabetes with hypertension;renal function

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 骆佩怡,李晓云
LUO Peiyi,LI Xiaoyun

参考文献(References)：

• [1]中华医学会糖尿病分会.中国2型糖尿病防治指南(2007年版)[M].2008,2-23.
• [2]杨巧红,李永胜,张书征.舒血宁注射液联合贝那普利治疗早期糖尿病肾病35例疗效观察[J].新中医,2007,08:92-93.
• [3]史勇.舒血宁联合贝那普利对2型糖尿病合并高血压肾损害的干预作用[J].中国药师,2012,03:385-387.
• [4]陈莉明.从中国糖尿病防治指南看糖尿病肾病的诊断和治疗[J].中国实用内科杂志,2009.29(6):513-515.
• [5]刘力生,龚兰生.中国高血压防治指南[M].2005修订版.北京:人民卫生出版社.2006.19-2l.
• [6]翁建平.糖尿病肾病的诊断与治疗[J].临床内科杂志,2005,22(3):150-153.
• [7]吕仁和.糖尿病及其并发症中西医诊治学[M].北京:人民卫生出版社,1997:513-527.
• [8]刘景群,刘启寿.贝那普利联合舒血宁治疗高血压左心舒张功能不全98例临床疗效观察[J].中国医药指南,2012,20:99-100.
• [9]黎雪玲.贝那普利联合拉西地平治疗高血压合并糖尿病患者早期肾损害的效果观察[J].内科,2013,04:350-351,355.
• [10]根富,胡东达.银杏叶制剂对冠心病患者血糖、胰岛索及血脂的影响[J].中国现代应用药学杂志,2009,26(7):605-606.
• [11]于欣,张保和,于美玲,等.TNF-αI、L-6与高血压肾损害的相关性及其受贝那普利的影响[J].中国实验诊断学,2011,03:492-495.